February 4, 2010
In continuing coverage, John B. Jemmott III, PhD was interviewed in a CBS3 Talk Philly segment regarding the abstinence-only intervention he developed. In light of a recent paper, a national discussion has emerged on the topic, with reporters from The Today Show, NPR, and others continuing to discuss the study's implications.
Click for clip - CBS3 Talk Philly
Click for clip - The Today Show
February 4, 2010
A PloS One study led by James Eberwine, PhD, co-director of the Penn Genome Frontiers Institute and the Elmer Holmes Bobst Professor of Pharmacology, was featured in Genetic Engineering & Biotechnology News. The results associate a modified form of a protein with three neurodegenerative diseases.
Click for article
February 3, 2010
Douglas H. Smith, MD was interviewed by the Milwaukee Journal Sentinel in an article discussing the use of unproven stem cell injections on patients seeking treatment for a variety of conditions, such as traumatic brain injuries.
Click for article
|
The Penn Comprehensive Neuroscience Center is dedicated to the advancement of the understanding of the brain, spine and peripheral nervous system.
Developing effective treatments and therapies for these areas requires the expertise, dedication and cooperation of scientists from many fields of research.
At Penn, the schools, centers, and institutes across our campus are brought together in the Penn CNC to create an integrated approach to patient
care, education and research.
Learn more about the Penn CNC
|
Read
Articles at 
